Hycult Biotech
As of October 1st, 2025, we’re pleased to announce a change in our management structure at Hycult Biotech. Our Managing Director, Ronald de Niet, is stepping back from daily operations to focus on strategy and long-term development as CEO. Marja van Genugten has been appointed COO, taking responsibility for day-to-day management and internal operations to support the company’s continued growth.
This new structure strengthens our foundation for the future and enables us to pursue our mission by providing high-quality tools for innate immunity research with even greater focus and impact.
New roles, Same expert team
Other interesting posts
